Permpongkosol Sompol, Chan David Y, Link Richard E, Sroka Myrna, Allaf Mohamad, Varkarakis Ioannis, Lima Guilherme, Jarrett Thomas W, Kavoussi Louis R
Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore 21287, USA.
J Urol. 2005 Oct;174(4 Pt 1):1222-5. doi: 10.1097/01.ju.0000173917.37265.41.
This report assesses the long-term oncological efficacy of laparoscopic radical nephrectomy compared with open radical nephrectomy in patients with clinically localized renal cell carcinoma.
We analyzed the data from 121 patients who underwent radical nephrectomy between 1991 and 1999 for clinical tumor stage T1/2 N0M0. The medical records of all patients were retrospectively reviewed with emphasis on tumor recurrence and survival. Statistical comparison was performed using Kaplan-Meier analysis.
The median followup was 73 months for the laparoscopic group and 80 months for the open group. Of the 67 patients who underwent laparoscopic surgery, 53 survived without any recurrence of disease, 2 are currently alive with metastasis, 2 died of metastatic disease in months 12 and 17, and 10 patients died without any disease recurrence. Laparoscopic port site metastasis did not develop in any patients. Of the 54 who underwent open surgery, 34 survived without any recurrence of disease, 1 currently has metastasis, 6 died of metastasis within 17 to 74 months, and 13 died without any disease recurrence. A comparison of the 5 and 10-year disease-free survival rates of the laparoscopic and open groups revealed no significant differences. In addition, the 5 and 10-year cancer specific and actuarial survival rates were not significantly different.
Based on long-term followup, our evaluation confirmed for clinical tumor stage T1/2 N0M0 that laparoscopic radical nephrectomy is oncologically equivalent to open radical nephrectomy.
本报告评估腹腔镜根治性肾切除术与开放性根治性肾切除术相比,对临床局限性肾细胞癌患者的长期肿瘤学疗效。
我们分析了1991年至1999年间因临床肿瘤分期为T1/2 N0M0而接受根治性肾切除术的121例患者的数据。对所有患者的病历进行回顾性审查,重点关注肿瘤复发和生存情况。使用Kaplan-Meier分析进行统计学比较。
腹腔镜组的中位随访时间为73个月,开放组为80个月。在接受腹腔镜手术的67例患者中,53例存活且无疾病复发,2例目前有转移存活,2例分别在第12个月和第17个月死于转移性疾病,10例患者无疾病复发死亡。所有患者均未发生腹腔镜切口部位转移。在接受开放手术的54例患者中,34例存活且无疾病复发,1例目前有转移,6例在17至74个月内死于转移,13例无疾病复发死亡。腹腔镜组和开放组5年和10年无病生存率比较无显著差异。此外,5年和10年癌症特异性生存率和精算生存率也无显著差异。
基于长期随访,我们的评估证实,对于临床肿瘤分期为T1/2 N0M0的患者,腹腔镜根治性肾切除术在肿瘤学上与开放性根治性肾切除术相当。